Format
Items per page
Sort by

Send to:

Choose Destination

Search results

Items: 1 to 20 of 102

1.

Emergent biomarker derived from next-generation sequencing to identify pain patients requiring uncommonly high opioid doses.

Kringel D, Ultsch A, Zimmermann M, Jansen JP, Ilias W, Freynhagen R, Griessinger N, Kopf A, Stein C, Doehring A, Resch E, Lötsch J.

Pharmacogenomics J. 2016 May 3. doi: 10.1038/tpj.2016.28. [Epub ahead of print]

PMID:
27139154
2.

Estimating the value of medical treatments to patients using probabilistic multi criteria decision analysis.

Broekhuizen H, Groothuis-Oudshoorn CG, Hauber AB, Jansen JP, IJzerman MJ.

BMC Med Inform Decis Mak. 2015 Dec 2;15:102. doi: 10.1186/s12911-015-0225-8.

3.

Tolerability, Safety, and Quality of Life with Tapentadol Prolonged Release (PR) Compared with Oxycodone/Naloxone PR in Patients with Severe Chronic Low Back Pain with a Neuropathic Component: A Randomized, Controlled, Open-label, Phase 3b/4 Trial.

Baron R, Jansen JP, Binder A, Pombo-Suarez M, Kennes L, Müller M, Falke D, Steigerwald I.

Pain Pract. 2015 Nov 11. doi: 10.1111/papr.12361. [Epub ahead of print]

PMID:
26554630
4.

Non-Comparative Trials To Supplement Network Meta-Analyses Using Arm-Specific Meta-Regression: An Application To Combination Therapies In Hiv.

Kanters S, Druyts E, Jansen JP, Mills EJ, Thorlund K.

Value Health. 2015 Nov;18(7):A683-4. doi: 10.1016/j.jval.2015.09.2524. Epub 2015 Oct 20. No abstract available.

PMID:
26533831
5.

Liraglutide vs Other Daily GLP-1 Analogues in People with Type 2 Diabetes: A Network Meta-Analysis.

Lorenzi M, Ploug UJ, Vega G, Jansen JP.

Value Health. 2015 Nov;18(7):A598-9. doi: 10.1016/j.jval.2015.09.2049. Epub 2015 Oct 20. No abstract available.

PMID:
26533358
6.

Evaluation of guideline-adherent treatment in cluster headache.

Lademann V, Jansen JP, Evers S, Frese A.

Cephalalgia. 2015 Oct 19. pii: 0333102415612774. [Epub ahead of print]

PMID:
26481303
7.

Erratum to: A Novel Dynamic Model for Health Economic Analysis of Influenza Vaccination in the Elderly.

Mullikin M, Tan L, Jansen JP, Van Ranst M, Farkas N, Petri E.

Infect Dis Ther. 2015 Dec;4(4):489-90. doi: 10.1007/s40121-015-0090-x. No abstract available.

8.

A Novel Dynamic Model for Health Economic Analysis of Influenza Vaccination in the Elderly.

Mullikin M, Tan L, Jansen JP, Van Ranst M, Farkas N, Petri E.

Infect Dis Ther. 2015 Dec;4(4):459-87. doi: 10.1007/s40121-015-0076-8. Epub 2015 Sep 9. Erratum in: Infect Dis Ther. 2015 Dec;4(4):489-90.

9.

Ranibizumab vs. aflibercept for wet age-related macular degeneration: network meta-analysis to understand the value of reduced frequency dosing.

Szabo SM, Hedegaard M, Chan K, Thorlund K, Christensen R, Vorum H, Jansen JP.

Curr Med Res Opin. 2015 Nov;31(11):2031-42. doi: 10.1185/03007995.2015.1084909. Epub 2015 Sep 28.

PMID:
26296050
10.

Test-retest reliability of skeletal muscle oxygenation measurements during submaximal cycling exercise in patients with chronic heart failure.

Niemeijer VM, Spee RF, Jansen JP, Buskermolen AB, van Dijk T, Wijn PF, Kemps HM.

Clin Physiol Funct Imaging. 2015 Jul 3. doi: 10.1111/cpf.12269. [Epub ahead of print]

PMID:
26147875
11.

New Formulation of Sustained Release Naloxone Can Reverse Opioid Induced Constipation Without Compromising the Desired Opioid Effects.

Sanders M, Jones S, Löwenstein O, Jansen JP, Miles H, Simpson K.

Pain Med. 2015 Aug;16(8):1540-50. doi: 10.1111/pme.12775. Epub 2015 Jun 24.

PMID:
26110375
12.

Characterization of exercise limitations by evaluating individual cardiac output patterns: a prospective cohort study in patients with chronic heart failure.

Spee RF, Niemeijer VM, Wessels B, Jansen JP, Wijn PF, Doevendans PA, Kemps HM.

BMC Cardiovasc Disord. 2015 Jun 23;15:57. doi: 10.1186/s12872-015-0057-6.

13.

The PRISMA extension statement for reporting of systematic reviews incorporating network meta-analyses of health care interventions: checklist and explanations.

Hutton B, Salanti G, Caldwell DM, Chaimani A, Schmid CH, Cameron C, Ioannidis JP, Straus S, Thorlund K, Jansen JP, Mulrow C, Catalá-López F, Gøtzsche PC, Dickersin K, Boutron I, Altman DG, Moher D.

Ann Intern Med. 2015 Jun 2;162(11):777-84. doi: 10.7326/M14-2385.

PMID:
26030634
15.

A randomized, placebo-controlled trial of lubiprostone for opioid-induced constipation in chronic noncancer pain.

Jamal MM, Adams AB, Jansen JP, Webster LR.

Am J Gastroenterol. 2015 May;110(5):725-32. doi: 10.1038/ajg.2015.106. Epub 2015 Apr 28.

16.

Network meta-analysis of longitudinal data using fractional polynomials.

Jansen JP, Vieira MC, Cope S.

Stat Med. 2015 Jul 10;34(15):2294-311. doi: 10.1002/sim.6492. Epub 2015 Apr 15.

PMID:
25877808
17.

Critical appraisal of network meta-analyses evaluating the efficacy and safety of new oral anticoagulants in atrial fibrillation stroke prevention trials.

Cope S, Clemens A, Hammès F, Noack H, Jansen JP.

Value Health. 2015 Mar;18(2):234-49. doi: 10.1016/j.jval.2014.10.012. Epub 2015 Jan 28. Review.

18.

Cost per remission and cost per response with infliximab, adalimumab, and golimumab for the treatment of moderately-to-severely active ulcerative colitis.

Toor K, Druyts E, Jansen JP, Thorlund K.

J Med Econ. 2015 Jun;18(6):437-46. doi: 10.3111/13696998.2015.1012513. Epub 2015 Feb 18.

PMID:
25629655
19.

Heterogeneity in meta-analysis of FDG-PET studies to diagnose lung cancer.

Mills EJ, Jansen JP, Kanters S.

JAMA. 2015 Jan 27;313(4):419. doi: 10.1001/jama.2014.16482. No abstract available.

PMID:
25626041
20.

Incorporating alternative design clinical trials in network meta-analyses.

Thorlund K, Druyts E, Toor K, Jansen JP, Mills EJ.

Clin Epidemiol. 2014 Dec 23;7:29-35. doi: 10.2147/CLEP.S70853. eCollection 2015.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk